GAA and glycogen storage disease II: Enzyme replacement therapy (ERT) with recombinant human acid alpha-glucosidase (rhGAA, alglucosidase alfa, Myozyme®, Sanofi Genzyme, Cambridge, MA) is available for the treatment of Pompe disease [5], [6].